Unraveling Insulin Resistance Mechanisms During Cardiopulmonary Bypass.
No abstract available
COI Statement
Conflicts of Interest, Funding: Please see DISCLOSURES at the end of this article.
References:
Schweizer T, Nossen C, Galova B, et al. In vitro investigation of insulin dynamics during 4 hours of simulated cardiopulmonary bypass. Anesth Analg. 2024;139:1591–1598.
Urban K, Redford D, Larson DF. Insulin binding to the cardiopulmonary bypass biomaterials. Perfusion. 2007;22:207–210.
Werb MR, Zinman B, Teasdale SJ, Goldman BS, Scully HE, Marliss EB. Hormonal and metabolic responses during coronary artery bypass surgery: role of infused glucose. J Clin Endocrinol Metab. 1989;69:1010–1018.
Karamanou M, Protogerou A, Tsoucalas G, Androutsos G, Poulakou-Rebelakou E. Milestones in the history of diabetes mellitus: the main contributors. World J Diabetes. 2016;7:1–7.
Reves JG, Karp RB, Buttner EE, et al. Neuronal and adrenomedullary catecholamine release in response to cardiopulmonary bypass in man. Circulation. 1982;66:49–55.